- Filed
- May 20, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 20, 2024 | 495.45M sh |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $2.55M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $3.35M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $278.18K |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $297.1K |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $283.35K |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $302.35K |
| Current Assets | Q1 2024 · Mar 31, 2024 | $2.66M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $3.46M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $2.67M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $3.46M |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 272.26M sh |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2023 | −$793.4K |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2023 | $135.5K |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2022 | $596.08K |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.00 |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $165.1K |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $298.77K |
| Net Income restated | Q1 2024 · Mar 31, 2023 | −$465.6K |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$468.9K |